Novartis
Stock
Stock
ISIN: CH0012005267
Ticker: NOVN
CH0012005267
NOVN
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 12.03.2026
$2.157
CHART BY
Frequently asked questions
What is Novartis's market capitalization?
The market capitalization of Novartis is $241.30B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Novartis's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Novartis is 21.11. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Novartis?
Novartis's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.001. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Novartis's stock?
Currently, 30 analysts cover Novartis's stock, with a consensus target price of $148.77. Analyst ratings provide insights into the stock's expected performance.
What is Novartis's revenue over the trailing twelve months?
Over the trailing twelve months, Novartis reported a revenue of $45.31B.
Is Novartis paying dividends?
Yes, Novartis is paying dividends. The next payment is scheduled for 12.03.2026, with an expected amount of .
What is the EBITDA for Novartis?
Novartis's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $18.41B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Novartis?
Novartis has a free cash flow of $14.61B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Novartis have, and what sector and industry does it belong to?
Novartis employs approximately 75,267 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
Financials
- Market Cap
- $241.30B
- EPS (TTM)
- $6.001
- P/E ratio (TTM)
- 21.11
- Revenue (TTM)
- $45.31B
- EBITDA (TTM)
- $18.41B
- Free Cashflow (TTM)
- $14.61B
Pricing
- 1D span
- $161.63$164.98
- 52W span
- $94.81$167.67
Analyst Ratings
The price target is $148.77 and the stock is covered by 30 analysts.
Buy
12
Hold
13
Sell
5
Information
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
- Employees
- 75,267
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- CH0012005267
- Primary Ticker
- NOVN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet